AcelRx PHARMACEUTICALS, Inc. (ACRX) Reporsts Q2 EPS Loss of $0.26
AcelRx PHARMACEUTICALS, Inc. (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)